banner
Aurora kinase inhibitor HOI-07, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ471

Aurora kinase inhibitor HOI-07, Purity ≥98%

Synonym: 1606160-40-0; HOI-07; (3Z)-3-[(E)-4-(1,3-Benzodioxol-5-yl)-2-oxobut-3-enylidene]-1H-indol-2-one; 2H-Indol-2-one, 3-[4-(1,3-benzodioxol-5-yl)-2-oxo-3-buten-1-ylidene]-1,3-dihydro-; EX-A3650; 3-(4-(Benzo[d][1,3]dioxol-5-yl)-2-oxobut-3-en-1-ylidene)indolin-2-one; Aurora kinase inhibitor

  • CAS Number: 1606160-40-0
  • Compound CID: 137699283
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
HOI-07 is an Aurora kinase inhibitor that disrupts cell division processes.
Molecular Weight
319.32
Molecular Formula
C19H13NO4
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
HOI-07 can be used for researching the dual inhibitory impact on Aurora kinases and HDACs in cancer treatments.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0